8-K current report · filed May 5, 2026

USANA HEALTH SCIENCES INC (USNA) 8-K Current Report: May 5, 2026

Item 2.02Item EX-99.1USNA overview

Short answer

USANA HEALTH SCIENCES INC (USNA) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q1 FY2026 results covered quarter ended April 4, 2026.

USANA HEALTH SCIENCES INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q1 FY2026 results covered quarter ended April 4, 2026
  • Financial results furnished through press release and Management Commentary in Exhibits 99.1 and 99.2
  • Investor conference call scheduled for management remarks and Q&A
  • Investors should review Exhibits 99.1 and 99.2 for operating metrics and outlook implications

Item EX-99.1 · Exhibit EX-99.1

  • Q1 net sales held flat at $250 million, but GAAP net earnings fell 20% to $7.5 million and diluted EPS declined to $0.41
  • Core Nutritional customers declined 12% to 404,000, signaling continued pressure on USANA’s legacy direct-sales engine
  • Greater China was the key stabilizer, with sales up 4% to $123 million and sequential growth of 23%
  • Rise Wellness sales surged 741% to $14 million, driven by Protein Pop’s nationwide Costco launch, but operating margin remained negative at 12.9%
  • Fiscal 2026 guidance was reaffirmed: consolidated sales $925 million–$1.0 billion, adjusted EPS $1.95–$2.29, and adjusted EBITDA $101 million–$109 million

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other USANA HEALTH SCIENCES INC 8-K filings

Get the next USNA 8-K as it lands

Follow USNA for push alerts, or ask the research agent what this filing means.